EBITDA at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's EBITDA?
- Adaptive Biotechnologies (ADPT) reported EBITDA of -$15.37M in Q1 2026.
- How has Adaptive Biotechnologies's EBITDA changed year-over-year?
- Adaptive Biotechnologies's EBITDA increased by 38.2% year-over-year, from -$24.87M to -$15.37M.
- What is the long-term trend for Adaptive Biotechnologies's EBITDA?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's EBITDA has grown at a -33.0% compound annual growth rate (CAGR), from -$195.01M to -$39.29M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.